Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  IMAC Holdings, Inc.    IMAC

IMAC HOLDINGS, INC.

(IMAC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

IMAC HOLDINGS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)

10/07/2020 | 04:48pm EST

Item 5.07. Submission of Matters to a Vote of Security Holders

On October 6, 2020, IMAC Holdings, Inc. (the "Company") held an annual meeting of its stockholders (the "Annual Meeting") at the Company's offices located at 1605 Westgate Circle, Brentwood, Tennessee 37027, at 11:00 a.m., local time. As of September 24, 2020, the record date of the Annual Meeting, there were a total of 11,839,972 shares of the Company's common stock issued and outstanding and entitled to vote at the Annual Meeting. A total of 9,163,585 votes were represented at the Annual Meeting, and a quorum was present. The following proposals were submitted to the shareholders:

1. the election of five directors nominated by the Company's board of directors (the "Board") named in the Proxy Statement (defined below);

2. the ratification of the appointment of Daszkal Bolton LLP as the Company's independent registered certified public accounting firm for the fiscal year ending December 31, 2020;

3. the approval (on an advisory, non-binding basis) of the compensation of the Company's named executive officers; and

4. the approval (on an advisory, non-binding basis), the frequency of the future advisory votes on the compensation of the Company's named executive officers (whether once every year, every two years or three years).

For more information about the foregoing proposals, please see the Company's Definitive Proxy Statement filed September 9, 2020 (the "Proxy Statement").

The number of votes cast for, against, and where applicable, votes withheld, as well as abstentions and broker non-votes and whether each proposal was approved, is set forth below.




1. The election of five directors nominated by the Board and named in the Proxy
Statement.



                            FOR         WITHHOLD       BROKER NON-VOTES
Jeffrey S. Ervin          4,553,527       14,487            4,595,571
Matthew C. Wallis         3,847,333       720,671           4,595,581
David K. Ellwanger        4,541,481       26,523            4,595,581
George P. Hampton         4,532,540       35,464            4,595,581
Gerard M. Hayden, Jr.     4,538,297       29,707            4,595,581



The five nominees listed above were elected to the Board. Consistent with the Company's certificate of incorporation, each director will serve until the Company's 2021 annual meeting of stockholders and, in each case, until a successor has been elected and qualified, or until his earlier death, resignation or removal.

2. The ratification of the appointment of Daszkal Bolton LLP as the Company's independent registered certified public accounting firm for the fiscal year ending December 31, 2020.



   FOR        AGAINST      ABSTAIN      BROKER NON-VOTES
9,034,325       44,804       84,456                 0











The appointment of Daszkal Bolton LLP as the Company's independent registered certified public accounting firm for the fiscal year ending December 31, 2020 was ratified.

3. The approval (on an advisory, non-binding basis) of the compensation of the Company's named executive officers.



   FOR         AGAINST      ABSTAIN       BROKER NON-VOTES
3,784,844       777,344       11,301           4,590,096



The proposal to approve, on an advisory, non-binding basis, the compensation of the Company's named executive officers, was approved.

4. The approval (on an advisory, non-binding basis), the frequency of the future advisory votes on the compensation of the Company's named executive officers (whether once every year, every two years or three years).



EVERY YEAR      EVERY TWO YEARS       EVERY THREE YEARS      ABSTAIN       BROKER NON-VOTES
3,504,593             25,143               1,027,982           15,771           4,590,096



The stockholders approved, on an advisory, non-binding basis, the frequency of future advisory votes on the compensation of the Company's named executive officers to be held every year.

© Edgar Online, source Glimpses

All news about IMAC HOLDINGS, INC.
11/13IMAC Holdings, Inc. To Participate in the Virtual Fall Investor Summit on No..
GL
11/13IMAC : To Participate in the Virtual Fall Investor Summit on November 16-18, 202..
AQ
11/12IMAC HOLDINGS, INC. : Results of Operations and Financial Condition, Financial S..
AQ
11/12IMAC : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS O..
AQ
11/12IMAC : Reports Third Quarter 2020 Financial Results
AQ
11/12IMAC Holdings Reports Third Quarter 2020 Financial Results
GL
11/11IMAC : Expands Missouri Footprint with Acquisition of Lockwood Chiropractic in W..
AQ
11/11IMAC Holdings, Inc. Expands Missouri Footprint with Acquisition of Lockwood C..
GL
11/05IMAC : Announces Opening Enrollment in Its Phase 1 Clinical Study of Umbilical C..
AQ
11/05IMAC Holdings, Inc. Announces Opening Enrollment in Its Phase 1 Clinical Stud..
GL
More news
Financials (USD)
Sales 2020 13,1 M - -
Net income 2020 -6,56 M - -
Net Debt 2020 - - -
P/E ratio 2020 -1,82x
Yield 2020 -
Capitalization 13,0 M 13,0 M -
Capi. / Sales 2020 0,99x
Capi. / Sales 2021 0,77x
Nbr of Employees 120
Free-Float 60,9%
Chart IMAC HOLDINGS, INC.
Duration : Period :
IMAC Holdings, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends IMAC HOLDINGS, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Average target price 3,75 $
Last Close Price 1,10 $
Spread / Highest target 332%
Spread / Average Target 241%
Spread / Lowest Target 150%
EPS Revisions
Managers
NameTitle
Jeffrey S. Ervin Chairman & Chief Executive Officer
Matthew C. Wallis Chief Operating Officer & Director
Sheri Gardzina Secretary, Chief Financial & Accounting Officer
Evans E. Maurice Independent Director
Michael D. Pruitt Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
IMAC HOLDINGS, INC.-26.67%13
AIER EYE HOSPITAL GROUP CO., LTD.103.94%38 900
FRESENIUS SE & CO. KGAA-24.93%25 003
IHH HEALTHCARE2.38%12 084
BANGKOK DUSIT MEDICAL SERVICES0.00%11 805
RAMSAY HEALTH CARE LIMITED-12.06%10 689